Literature DB >> 832533

Fosfomycin in acute bronchopneumopathies.

J Honorato, R Pérez Ortola, R Masso, J M Reparaz.   

Abstract

Fosfomycin has been tested in 25 adult patients with bronchial or bronchopulmonary acute processes, of which 13 were simple acute processes of a greater or lesser severity, and 12 acutenesses of chronic bronchial processes. The germs found most frequently in the sputum cultures were Streptococcus pneumoniae and Klebsiella. Fosfomycin was used intramuscularly with doses of 4 g/day, for an average of 10 days. The results obtained were 16 cures, 7 improvements and 2 failures, which represents 92% success with 8% failures.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 832533     DOI: 10.1159/000222071

Source DB:  PubMed          Journal:  Chemotherapy        ISSN: 0009-3157            Impact factor:   2.544


  1 in total

1.  Fosfomycin-ampicillin versus gentamicin-ampicillin in the treatment of critically ill patients with pneumonia.

Authors:  L R Nissen; J Jacobsen; T J Ravn; C Wahlgreen; H Auning-Hansen
Journal:  Infection       Date:  1986 Sep-Oct       Impact factor: 3.553

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.